OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q2 2021 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q2 2021 Earnings Conference Call August 05, 2021, 16:30 ET Company Participants Ben Atkins - VP, Communications & IR Roger Crystal - President, CEO & Director David O'Toole - CFO Conference Call Participants Carl Byrnes - Northland Capital Markets David Bautz - Zacks Investment Research Presentation Operator Good day, and welcome to the Opiant Pharmaceuticals Second Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Ben Atkins, Vice President of Communications and Investor Relations. Please go ahead, sir. Ben Atkins Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Dr. Roger Crystal; and Chief Financial Officer, David O'Toole. This afternoon, Opiant issued a press release announcing financial results and providing a business update for the 3 and 6 months ended June

For further details see:

Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2021 Results - Earnings Call Transcript